ML-007

N/A

Report date: 2023/09/04 15:00:10
NME

Base Information

Drug NameML-007
Drug Alias NameML-007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M1 agonistsMuscarinic acetylcholine receptor M4 agonistsNeurons modulators
TargetsMuscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M4
Therapy Area/IndicationsSchizophreniaDyskinesias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMapLight Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSchizophreniaDyskinesias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A